ATE178493T1 - Stabilisierte antikörperfragmente - Google Patents

Stabilisierte antikörperfragmente

Info

Publication number
ATE178493T1
ATE178493T1 AT92906121T AT92906121T ATE178493T1 AT E178493 T1 ATE178493 T1 AT E178493T1 AT 92906121 T AT92906121 T AT 92906121T AT 92906121 T AT92906121 T AT 92906121T AT E178493 T1 ATE178493 T1 AT E178493T1
Authority
AT
Austria
Prior art keywords
fragments
methods
antibody fragments
molecules
stabilized antibody
Prior art date
Application number
AT92906121T
Other languages
English (en)
Inventor
John M Reno
Becky J Bottino
Original Assignee
Neorx Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neorx Corp filed Critical Neorx Corp
Application granted granted Critical
Publication of ATE178493T1 publication Critical patent/ATE178493T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT92906121T 1991-01-30 1992-01-17 Stabilisierte antikörperfragmente ATE178493T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US64777991A 1991-01-30 1991-01-30

Publications (1)

Publication Number Publication Date
ATE178493T1 true ATE178493T1 (de) 1999-04-15

Family

ID=24598239

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92906121T ATE178493T1 (de) 1991-01-30 1992-01-17 Stabilisierte antikörperfragmente

Country Status (7)

Country Link
US (1) US5506342A (de)
EP (1) EP0569531B1 (de)
JP (1) JPH06505480A (de)
AT (1) ATE178493T1 (de)
CA (1) CA2098097A1 (de)
DE (1) DE69228869T2 (de)
WO (1) WO1992013557A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6171586B1 (en) * 1997-06-13 2001-01-09 Genentech, Inc. Antibody formulation
US6991790B1 (en) 1997-06-13 2006-01-31 Genentech, Inc. Antibody formulation
US20050175619A1 (en) * 2004-02-05 2005-08-11 Robert Duffy Methods of producing antibody conjugates

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4867973A (en) * 1984-08-31 1989-09-19 Cytogen Corporation Antibody-therapeutic agent conjugates
US4470925A (en) * 1982-05-05 1984-09-11 E. I. Du Pont De Nemours And Company Immunoglobulin half-molecules and process for producing hybrid antibodies
US4657853A (en) * 1984-09-14 1987-04-14 E. I. Du Pont De Nemours And Company Immunoassays utilizing covalent conjugates of polymerized enzyme and antibody
US5055561A (en) * 1985-11-19 1991-10-08 The Johns Hopkins University Protein label and drug delivery system
US4877868A (en) * 1986-03-12 1989-10-31 Neorx Corporation Radionuclide antibody coupling
FR2641468A1 (fr) * 1989-01-11 1990-07-13 Merieux Inst Anticorps chimeriques anti-recepteur de l'interleukine-2 humaine, leur preparation et compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
EP0569531A4 (de) 1994-11-17
EP0569531B1 (de) 1999-04-07
DE69228869T2 (de) 1999-08-05
DE69228869D1 (de) 1999-05-12
CA2098097A1 (en) 1992-07-30
JPH06505480A (ja) 1994-06-23
WO1992013557A1 (en) 1992-08-20
EP0569531A1 (de) 1993-11-18
US5506342A (en) 1996-04-09

Similar Documents

Publication Publication Date Title
DK499086D0 (da) Konjugater af trichothecen og anvendelse af samme som terapeutisk substans
DE69637730D1 (de) Verfahren zur in vito vorbehandlung von myoblasten vor deren transplantation
CA2090700A1 (en) Modified antibodies with controlled clearance time
FI950062A0 (fi) Proteiinien foroaktivaatio konjugaatiotarkoituksia varten
RU94022254A (ru) Лиганды, содержащие гетероатом, их комплексы с металлами, способ получения, способ лечения и применение в диагностических наборах
AU2739188A (en) Novel antibodies
DE69434086D1 (de) Herstellung und Verwendung von Immunkonjugaten die eine VL-Kette enthalten welche am Asn in Position 18 glykosyliert ist
NO985120D0 (no) Monoklonalt antistoff mot CEA, konjugater omfattende nevnte antistoff og deres terapeutiske anvendelse i et adeptsystem
DK0765343T3 (da) Monoklonale antistoffer imod CD44v6
AU8366398A (en) Trifunctional reagent for conjugation to a biomolecule
DK0433088T3 (da) Monoklonale antistoffer, der reagerer med et humant atheromaassocieret antigen
NO317485B1 (no) Fremgangsmate for fremstilling av ZME-018 gelonin immunokonjugat for behandling av melanom
DE3789788D1 (de) Aminderivate von Folsäure Analogen.
RO82758A (ro) Procedeu de preparare a unor imunoglobulinei conjugate
DE69516403D1 (de) Photodynamische konjugate mit biozide eigenschaften
ES8800437A1 (es) Un procedimiento para la produccion de un conjugado marcado con un trazador de metalotioneina y una molecula biologicamente activa
FI891718A0 (fi) Foerfarande foer att befria cellblandningar och vaevnader av icke-oenskade populationer.
ATE178493T1 (de) Stabilisierte antikörperfragmente
ATE168695T1 (de) Glycosyl-etoposid-prodrugs, verfahren zu ihrer herstellung und ihre anwendung in kombination mit funktionalisierten tumorspezifischen enzym- konjugaten
ATE67507T1 (de) Immunotoxine, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ES2057572T3 (es) Agentes de reconocimiento.
DE69724761D1 (de) Biotinylierter antikörper mit verminderter positiver nettoladung und toxin, medikament oder chelat
ATE97324T1 (de) Verwendung von amphipatischen molekuelen zur radiodarstellung und therapie mittels monoklonaler oder polyklonaler antikoerperkonjugate.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties